Brandywine Oak Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.82M Sell
11,196
-22
-0.2% -$4.73K 0.21% 56
2026
Q1
$2.44M Sell
11,218
-112
-1% -$24.8K 0.21% 61
2025
Q4
$2.59M Sell
11,330
-101
-0.9% -$23K 0.22% 57
2025
Q3
$2.65M Sell
11,431
-601
-5% -$122K 0.23% 57
2025
Q2
$2.23M Hold
12,032
0.21% 59
2025
Q1
$2.52M Sell
12,032
-9
-0.1% -$1.75K 0.25% 53
2024
Q4
$2.14M Sell
12,041
-1,465
-11% -$269K 0.21% 61
2024
Q3
$2.67M Buy
13,506
+57
+0.4% +$10.6K 0.26% 54
2024
Q2
$2.31M Sell
13,449
-701
-5% -$116K 0.24% 57
2024
Q1
$2.58M Buy
14,150
+365
+3% +$62.9K 0.27% 52
2023
Q4
$2.14M Sell
13,785
-329
-2% -$48K 0.24% 58
2023
Q3
$2.1M Sell
14,114
-12
-0.1% -$1.76K 0.25% 57
2023
Q2
$1.9M Buy
14,126
+124
+0.9% +$18.2K 0.21% 63
2023
Q1
$2.23M Sell
14,002
-21
-0.1% -$3.21K 0.26% 56
2022
Q4
$2.27M Sell
14,023
-1,299
-8% -$199K 0.28% 54
2022
Q3
$2.06M Sell
15,322
-161
-1% -$23.1K 0.28% 56
2022
Q2
$2.37M Sell
15,483
-470
-3% -$71.8K 0.3% 52
2022
Q1
$2.59M Buy
15,953
+32
+0.2% +$4.65K 0.3% 60
2021
Q4
$2.15M Buy
15,921
+451
+3% +$53.3K 0.24% 72
2021
Q3
$1.67M Buy
15,470
+832
+6% +$95.1K 0.19% 81
2021
Q2
$1.65M Buy
14,638
+8,019
+121% +$903K 0.19% 82
2021
Q1
$716K Sell
6,619
-14
-0.2% -$1.5K 0.11% 118
2020
Q4
$710K Buy
6,633
+175
+3% +$16.8K 0.11% 111
2020
Q3
$565K Buy
6,458
+86
+1% +$8.1K 0.09% 128
2020
Q2
$625K Buy
6,372
+876
+16% +$77.1K 0.11% 112
2020
Q1
$418K Sell
5,496
-41
-0.7% -$3.49K 0.09% 128
2019
Q4
$490K Buy
5,537
+7
+0.1% +$581 0.09% 113
2019
Q3
$418K Buy
5,530
+1,827
+49% +$125K 0.08% 123
2019
Q2
$269K Buy
3,703
+37
+1% +$2.91K 0.05% 178
2019
Q1
$295K Sell
3,666
-1,501
-29% -$123K 0.06% 158
2018
Q4
$476K Buy
+5,167
New +$454K 0.11% 100

Other funds holding ABBV

Brandywine Oak Private Wealth's ABBV Position: Q2 2026 in Review

Brandywine Oak Private Wealth reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $4.73K and leaving 11,196 shares worth $2.82M. The position accounts for 0.21% of the portfolio, ranked #56.

Brandywine Oak Private Wealth first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brandywine Oak Private Wealth held 11,196 shares of AbbVie worth $2.82M as of Q2 2026.
  • Brandywine Oak Private Wealth sold 22 AbbVie shares in Q2 2026, an estimated $4.73K.
  • AbbVie made up 0.21% of Brandywine Oak Private Wealth's portfolio in Q2 2026, its #56 holding.
  • Brandywine Oak Private Wealth first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brandywine Oak Private Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.